Steris (STE) Receivables - Other (2019 - 2020)

Name: Steris (STE) Receivables - Other (2019 - 2020) | Business Quant
Creator: Business Quant

Steris' quarterly Receivables - Other came in at $9.0 million in Q4 2020, up 4.93% quarter-over-quarter from $8.5 million in Q3 2020.

Steris has reported Receivables - Other for 2 years, with the latest figure at $9.0 million in Q4 2020.

For the quarter ending Q4 2020, Receivables - Other changed N/A year-over-year to $9.0 million; the trailing twelve-month figure through Dec 2020 stood at $9.0 million (changed N/A YoY), and the FY2020 full-year result was $8.1 million, down 4.97% from the prior year.
Receivables - Other for Q4 2020 stood at $9.0 million, up from $8.5 million in the prior quarter.
The five-year high for Receivables - Other was $9.0 million in Q4 2020, with the low at $8.1 million in Q1 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn
10	Zimmer Biomet Holdings	16.17 Bn	15.75 Bn	1.51 Bn

Download Data 🔒